RxDoctor Payments Data

Aubree Welsh, APRN

Women's Health · Kennesaw, GANPI 1215498654

Payments from drug & device makers

$541in general payments, 2019–2025

Across 28 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myovant Sciences Inc.$130
  • Sage Therapeutics, LLC$108
  • AbbVie$104
  • Mayne Pharma Commercial LLC$67
  • Astellas Pharma US Inc$51
  • Bayer$31
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$541100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$541 in reported general payments places this provider in the 65th percentile of 247 women's health providers in Georgia.

See all women's health providers in Georgia

Medicare billing

Part B allowed, 2024
$5,846
Medicare patients
45
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol11$543
Clobetasol Propionate14$460
Metronidazole11$352

Paid to pharmacies, not to this prescriber.

Other women's health in Kennesaw

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →